Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.37 |
| ▸ | CHRNA10 | Q9GZZ6 | 3/20 | 0.37 |
| ▸ | CHRNA9 | Q9UGM1 | 3/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514398 | 0.92 | RELA (0.40) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL5373678 | 0.89 | RELA (0.43) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL4543864 | 0.87 | RELA (0.41) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL13686299 | 0.86 | MAOB (0.48) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL11212657 | 0.84 | ALDH1A1 (0.47) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL28174614 | 0.83 | LTA4H (0.40) | RELACHRNA7MEN1KMT2AALDH1A1 | |
| SCHEMBL2098848 | 0.82 | RELA (0.46) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL60042 | 0.82 | RELA (0.53) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| Benzene SCHEMBL28121960 | 0.82 | RELA (0.53) | RELACHRNA7MEN1KMT2ACYP1A2 | |
| SCHEMBL17836905 | 0.82 | RELA (0.53) | RELACHRNA7MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118732392-A | Photoresist composition and preparation method thereof | 万华化学集团股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118295208-A | Chemical amplification type photoresist and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| EP-1465877-B1 | POSITIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING | AZ ELECTRONIC MATERIALS USA (US) | 2008-09-24 | — | — | EP | claimed |
| US-6887877-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2005-05-03 | — | — | US | claimed |
| EP-1395571-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Shire Biochem Inc. (CA) | 2004-03-10 | — | — | EP | claimed |
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | SHIRE BIOCHEM INC. (CA) | 2003-12-11 | — | — | US | claimed |
| WO-2002100846-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | SHIRE BIOCHEM INC. (CA) | 2002-12-19 | — | — | WO | claimed |
| CN-119126488-A | Resist topcoat composition and method of forming pattern using the same | 三星SDI株式会社 | 2024-12-13 | — | — | CN | disclosed |
| CN-118732392-A | Photoresist composition and preparation method thereof | 万华化学集团股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118295208-A | Chemical amplification type photoresist and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-105474099-B | Laminated body | 富士胶片株式会社 | 2019-09-03 | — | — | CN | disclosed |
| CN-109791359-A | Anti-corrosion agent composition and resist pattern forming method, high-molecular compound and copolymer | 东京应化工业株式会社 | 2019-05-21 | — | — | CN | disclosed |
| CN-105474099-A | Laminate body | FUJIFILM CORP | 2016-04-06 | — | — | CN | disclosed |
| EP-1143296-A2 | Method for forming pattern | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-6210859-B1 | SENSITIVITY, RESOLUTION, HEAT-RESISTANCE AND STABILITY AFTER EXPOSURE, ULTRAFINE PATTERNS CAN BE FORMED IRRESPECTIVE OF ANY SUBSTRATE, LARGER SCOPE OF EXPOSURE CAN BE OBTAINED, A MODIFIEDPOLYHYDROXYSTYRENE COPOLYMER | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2001-04-03 | — | — | US | disclosed |
| EP-1059563-A1 | Agent for reducing substrate dependence of resist | Wako Pure Chemical Industries, Ltd. (JP) | 2000-12-13 | — | — | EP | disclosed |
| EP-1059314-A1 | A resist composition | Wako Pure Chemical Industries, Ltd. (JP) | 2000-12-13 | — | — | EP | disclosed |
| US-5856069-A | T-SHAPED PATTERN | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-01-05 | — | — | US | disclosed |
| US-5756262-A | COATING SUBSTRATE, EXPOSURE THROUGH MASK IN PREFERENTIAL HUMIDITY SETTING, DEVELOPMENT | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0747767-A2 | Method for forming pattern | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | HAVCR2, ZC3HAV1, MAVS | RELA 1915/4885CHRNA7 4802/4885MEN1 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.